Download Free Sample Report

The global Clinical Trial Supply and Logistics market was valued at US$ 11880 million in 2022 and is projected to reach US$ 18120 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Clinical trial companies, also known as contact manufactures or CROs, offer development and research, and manufacturing services on a contract basis to pharmaceutical and biotechnology vendors as well as government institutions, foundations, and universities. The clinical trial industry uses outbound logistics for the complete management of the way resources are acquired, stored, and moved to different end- users or markets. The use of inbound logistics helps the clinical trial industry have a continual supply of drugs, equipment, and devices from suppliers and distributors in different locations.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply and Logistics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply and Logistics. This report contains market size and forecasts of Clinical Trial Supply and Logistics in global, including the following market information:

• Global Clinical Trial Supply and Logistics Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global top five companies in 2022 (%)

The USA market for Global Peak Flowmeter market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Peak Flowmeter market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Peak Flowmeter market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Continuous emphasis by the manufacturers towards balancing shipment and supply costs, optimizing production and packaging and minimizing overage and avoiding shortages, are propelling the demand for efficient solutions for clinical trial supply and logistics. Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will also augment the demand for regional depot network with strong transport networks to trial sites.

We surveyed the Clinical Trial Supply and Logistics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trial Supply and Logistics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Clinical Trial Supply and Logistics Market Segment Percentages, by Type, 2022 (%)

• Product
• Service

Global Clinical Trial Supply and Logistics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Clinical Trial Supply and Logistics Market Segment Percentages, by Application, 2022 (%)

• Biopharmaceutical
• Medical Industry
• Others

Global Clinical Trial Supply and Logistics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Clinical Trial Supply and Logistics Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Trial Supply and Logistics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Trial Supply and Logistics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Deutsche Bahn
• DHL
• FedEx
• UPS
• Agility
• Air Canada Cargo
• Avinex Ukr
• Biocair International
• Biotec Services International
• CEVA
• Cold Chain Technologies
• Continental Air Cargo
• CSafe Global
• Helapet
• Igloo Thermo-Logistics
• Kerry Logistics
• Kuehne + Nagel International
• L&M Transportation Services
• LifeConEx
• Marken
• Nordic Cold Storage
• Panalpina World Transport
• Sofrigam
• TNT Express
• UTi Pharma
• VersaCold

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Clinical Trial Supply and Logistics, market overview.
• Chapter 2: Global Clinical Trial Supply and Logistics market size in revenue.
• Chapter 3: Detailed analysis of Clinical Trial Supply and Logistics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Clinical Trial Supply and Logistics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.